PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target ; volume:20 ; number:1 ; day:18 ; month:4 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of neuroinflammation ; 20, Heft 1 (18.4.2023), 1-19, 12.2023
- Creator
-
Lind-Holm Mogensen, Frida
Scafidi, Andrea
Poli, Aurélie
Michelucci, Alessandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-023-02776-z
- URN
-
urn:nbn:de:101:1-2023082921151245366865
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lind-Holm Mogensen, Frida
- Scafidi, Andrea
- Poli, Aurélie
- Michelucci, Alessandro
- SpringerLink (Online service)
Other Objects (12)
Therapeutic drug monitoring in Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Function of Dj-1 in the pathoetiology of Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Function of Dj-1 in the pathoetiology of Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches